| Literature DB >> 15598614 |
Magali Taulan1, François Paquet, Christophe Maubert, Olivia Delissen, Jacques Demaille, Marie-Catherine Romey.
Abstract
Although the nephrotoxicity of uranium has been established through numerous animal studies, relatively little is known about the effects of long-term environmental uranium exposure. Using a combination of conventional biochemical studies and serial analysis of gene expression (SAGE), we examined the renal responses to uranyl nitrate (UN) chronic exposure. Renal uranium levels were significantly increased 4 months after ingestion of uranium in drinking water. Creatinine levels in serum were slightly but significantly increased compared with those in controls. Although no further significant differences in other parameters were noted, substantial molecular changes were observed in toxicogenomic profiles. UN induced dramatic alterations in expression levels of more than 200 genes, mainly up-regulated, including oxidative-response-related genes, genes encoding for cellular metabolism, ribosomal proteins, signal transduction, and solute transporters. Seven differentially expressed transcripts were confirmed by real-time quantitative polymerase chain reaction. In addition, significantly increased peroxide levels support the implication of oxidative stress in UN toxicant response. This report highlights the potential of SAGE for the discovery of novel toxicant-induced gene expression alterations. Here, we present, for the first time, a comprehensive view of renal molecular events after uranium long-term exposure.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15598614 PMCID: PMC1247660 DOI: 10.1289/txg.7296
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
SYBR Green and TaqMan primer sequences used for RT-PCR reactions.
| Gene symbol | Gene name | Accession no. | Primer 5′→3′ sequence or assay ID | Amplicon size (bp) |
|---|---|---|---|---|
| Primers using SYBR Green detection | ||||
| | hypoxanthine phosphoribosyl transferase | NM_013556 | Forward 5′-TTGCTGACCTGCTGGATTAC-3′ | 112 |
| Reverse 5′-CCCGTTGACTGATCATTACA-3′ | ||||
| | superoxide dismutase 1 | XM_128337 | Forward 5′-TGGTGGTCCATGAGAAACAA-3′ | 75 |
| Reverse 5′-TCCCAGCATTTCCAGTCTTT-3′ | ||||
| | ornithine decarboxylase, structural | NM_013614 | Forward 5′-TTGCCACTGATGATTCCAAA-3′ | 129 |
| Reverse 5′-CATGGAAGCTCACACCAATG-3′ | ||||
| | Finkel-Biskis-Reilly murine sarcoma virus | NM_007990 | Forward 5′-GCTGGGAGGTAAAGTTCACG-3′ | 125 |
| Reverse 5′-TGTACTGCATTCGCCTCTTG-3′ | ||||
| | translationally regulated transcript | NM_009429 | Forward 5′-CCGGGAGATCGCGGAC-3′ | 92 |
| Reverse 5′-TTCCACCGATGAGCGAGTC-3′ | ||||
| Primers using TaqMan technology | ||||
| | hypoxanthine phosphoribosyl transferase | NM_013556 | Mm00446968m1 | |
| | kidney androgen regulated protein | NM_010594 | Mm00495104m1 | |
| | solute carrier family 34, member 1 | NM_011392 | Mm00441450m1 | |
| | uromodulin | NM_009470 | Mm00447649m1 | |
From Applied Biosystems (http://myscience.appliedbiosystems.com/cdsEntry/Form/gene_expression_keyword.jsp).
Primer 5′→3′ sequence.
Assay ID – Applied Biosystems.
Physiologic parameters in serum and urine and uranium amount in control group 0 and contaminated groups 1 and 2 after 4 months of daily contamination (mean ± SE).
| Group
| |||
|---|---|---|---|
| Parameter | 0 | 1 | 2 |
| Exposure (mg UN/L) | 0 | 80 | 160 |
| Kidney | |||
| Weight (g) | 0.47 ± 0.01 | 0.46 ± 0.01 | 0.47 ± 0.02 |
| Uranium amount (μg/g) | 0.16 ± 0.04 | 0.35 ± 0.02 | 1.05 ± 0.21 |
| Serum | |||
| Urea (mg/dL) | 59 ± 5 | 57 ± 5 | 54 ± 7 |
| Creatinine (mg/dL) | 0.12 ± 0.02 | 0.23 ± 0.02 | 0.25 ± 0.02 |
| Urine | |||
| Glucose (g/L) | 0.08 ± 0.03 | 0.08 ± 0.03 | 0.04 ± 0.01 |
| γ -GT (U/L) | 86 ± 44 | 94 ± 42 | 119 ± 66 |
*p < 0.05 versus control; n = 4.
List of tags with significant variations in expression level induced by UN long-term ingestion (p < 0.05), their frequency, and their relevant accession number.
| Tag sequence | Count
| Gene name | Accession no. | Regulation | Gene symbol | |
|---|---|---|---|---|---|---|
| UN(−) | UN(+) | |||||
| GCTGCCAGGG | 11 | 4 | Bcl2-associated athanogene 1 | NM_009736 | − | |
| GAAAGCAATG | 0 | 6 | nerve growth factor receptor (TNFRSF16) associated protein 1 | NM_009750 | + | |
| TGCCTTACTT | 3 | 8 | programmed cell death 6 | NM_011051 | + | |
| CGTATCTGTA | 4 | 10 | D-amino acid oxidase | NM_010018 | + | |
| CAGTTACAAA | 1 | 6 | glutamate dehydrogenase | NM_008133 | + | |
| TTTTACCTGC | 0 | 8 | glycine amidinotransferase (L-arginine:glycine amidinotransferase) | NM_025961 | + | |
| CTACCACTGC | 4 | 12 | fumarylacetoacetate hydrolase | NM_010176 | + | |
| ATACTAACGT | 40 | 24 | ornithine decarboxylase, structural | NM_013614 | − | |
| AACAGAAAGT | 1 | 8 | phenylalanine hydroxylase | NM_008777 | + | |
| GCAAACAAGA | 11 | 18 | isocitrate dehydrogenase 2 (NADP+), mitochondrial | NM_173011 | + | |
| GTGCCATATT | 12 | 26 | isocitrate dehydrogenase 2 (NADP+), mitochondrial | NM_173011 | + | |
| /CCAAATAAAA | 17 | 31 | lactate dehydrogenase 1, A chain | NM_010699 | + | |
| TGATATGAGC | 33 | 12 | lactate dehydrogenase 2, B chain | NM_008492 | − | |
| TTGTTAGTGC | 70 | 89 | malate dehydrogenase, soluble | NM_008492 | + | |
| GCAATCTGAT | 17 | 31 | phosphoglycerate kinase 1 | NM_008828 | + | |
| GCCCAGACCT | 25 | 41 | sorbitol dehydrogenase 1 | NM_146126 | + | |
| GCTTGTGACG | 1 | 8 | transaldolase 1 | NM_011528 | + | |
| CTCTGACTTA | 3 | 8 | basigin | NM_009768 | + | |
| GAGACTAGCA | 4 | 10 | transmembrane 4 superfamily member 8 | NM_019793 | + | |
| GTTCAAGTGA | 4 | 12 | Ia-associated invariant chain | NM_010545 | + | |
| TATCCTGAAT | 14 | 2 | lymphocyte antigen 6 complex, locus A | NM_010738 | − | |
| TTTTATGTTT | 12 | 20 | tumor necrosis factor, alpha-induced protein 1 (endothelial) | NM_009395 | + | |
| TATACATCCA | 43 | 26 | uromodulin | NM_009470 | − | |
| TGGGTTGTCT | 151 | 174 | translationally regulated transcript (21 kDa) | NM_009429 | + | |
| CTATCCTCTC | 297 | 341 | glutathione peroxidase 3 | NM_008161 | + | |
| CAGCTTCGAA | 12 | 2 | glutathione S-transferase, theta 2 | NM_010361 | − | |
| AGAAACAAGA | 7 | 18 | superoxide dismutase 1, soluble | XM_128337 | + | |
| TTGCTTCTAT | 20 | 8 | thioether S-methyltransferase | NM_009349 | − | |
| CATCAGCCTC | 7 | 0 | thioredoxin, mitochondrial | NM_019913 | − | |
| TCTCCTTAGC | 0 | 10 | ATP-binding cassette, subfamily D (ALD), member 3 | NM_008991 | + | |
| TTAAGACCTG | 9 | 18 | crystallin, zeta | NM_009968 | + | |
| TATAATAAAC | 0 | 8 | cytochrome P450, 2d9 | NM_080006 | + | |
| TGTGTGGAAT | 14 | 20 | cytochrome P450, subfamily IV B, polypeptide 1 | NM_007823 | + | |
| GGAGGGTGTG | 4 | 10 | phosphatidic acid phosphatase type 2c | NM_015817 | + | |
| CCTCCCTTTT | 4 | 14 | heat shock 10 kDa protein 1 (chaperonin 10) | NM_008303 | + | |
| GATGTGGCTG | 7 | 22 | eukaryotic translation elongation factor 1 beta 2 | NM_018796 | + | |
| TCACCCAATA | 36 | 49 | eukaryotic translation elongation factor 2 | NM_007907 | + | |
| CTAATAAAGC | 18 | 43 | Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived) | NM_007990 | + | |
| TGTCATCTAG | 7 | 14 | laminin receptor 1 (67 kDa, ribosomal protein SA) | NM_011029 | + | |
| TGCTGGGATG | 6 | 16 | mitochondrial ribosomal protein S12 | NM_011885 | + | |
| AGGTCGGGTG | 7 | 14 | ribosomal protein L13a | + | ||
| TGGATCAGTC | 47 | 66 | ribosomal protein L19 | NM_009078 | + | |
| CCAGAACAGA | 7 | 20 | ribosomal protein L30 | NM_009078 | + | |
| GGCTTCGGTC | 48 | 68 | ribosomal protein, large, P1 | NM_018853 | + | |
| GTGAAACTAA | 36 | 45 | ribosomal protein S4, X-linked | NM_009094 | + | |
| CTGGGCGTGT | 3 | 8 | ribosomal protein S15 | NM_009091 | + | |
| GTGGGCGTGT | 0 | 6 | ribosomal protein S15 | NM_009091 | + | |
| CAGAACCCAC | 0 | 6 | ribosomal protein S18 | NM_138946 | + | |
| GCCTTTATGA | 4 | 10 | ribosomal protein S24 | NM_011297 | + | |
| AACAGGTTCA | 11 | 18 | ribosomal protein S25 | NM_024266 | + | |
| TAAAGAGGCC | 18 | 29 | ribosomal protein S26 | NM_013765 | + | |
| GGTTAAATGT | 1 | 8 | cathepsin L | NM_009984 | + | |
| CAGCAAAAAA | 33 | 41 | kallikrein 5 | NM_008456 | + | |
| GAGAGTGTGA | 6 | 14 | kidney-derived aspartic protease-like protein | NM_008437 | + | |
| CAGAATGGAA | 14 | 29 | peptidase 4 | NM_008820 | + | |
| AGGCGGGATC | 3 | 8 | proteasome (prosome, macropain) subunit, alpha type 7 | NM_011969 | + | |
| CAACAAACAT | 3 | 10 | protein C | NM_008934 | + | |
| GTAAGCAAAA | 22 | 43 | ubiquitin B | NM_011664 | + | |
| TGGGACTCAC | 4 | 14 | cholecystokinin A receptor | NM_009827 | + | |
| AGAAAAAAAA | 7 | 14 | ciliary neurotrophic factor receptor | NM_016673 | + | |
| TGATTTTTGT | 1 | 10 | disabled homolog 2 (Drosophila) | NM_023118 | + | |
| GGGCAAGCCA | 4 | 14 | estrogen-related receptor, alpha | NM_007953 | + | |
| CATACGCATA | 7 | 16 | growth hormone receptor | NM_010284 | + | |
| TTAAGAGGGA | 12 | 0 | transducer of ErbB-2.1 | NM_009427 | − | |
| GCTTTGAATG | 20 | 35 | ATPase inhibitor | NM_007512 | + | |
| CCAGTCCTGG | 12 | 24 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 1 | NM_007506 | + | |
| GTTCTTTCGT | 3 | 8 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 2 | NM_026468 | + | |
| GCCGAGCATA | 6 | 16 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit f, isoform 2 | NM_020582 | + | |
| GATAGATAAT | 3 | 8 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1 | NM_007505 | + | |
| CTAATAAAAG | 33 | 45 | cytochrome c oxidase, subunit IVa | NM_009941 | + | |
| TATTGGCTCT | 53 | 74 | cytochrome c oxidase, subunit VIIIa | NM_007750 | + | |
| AGGGCACTGG | 3 | 8 | cytochrome c oxidase, subunit XVII assembly protein homolog | AV158262 | + | |
| CAGAATGTGC | 3 | 8 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 | NM_010885 | + | |
| TTATGAAATG | 15 | 24 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1 | NM_019443 | + | |
| ACTGCTTTTC | 1 | 10 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 | NM_023202 | + | |
| TTCTAGCATA | 28 | 10 | ATPase, Na+/K+ transporting, beta 1 polypeptide | NM_009721 | − | |
| CTAGGTACTG | 48 | 91 | solute carrier family 34 (sodium phosphate), member 1 | NM_011392 | + | |
| ACAAATTATG | 1 | 8 | voltage-dependent anion channel 2 | NM_011695 | + | |
| GCTCTGATAC | 0 | 8 | sterol carrier protein 2, liver | NM_138508 | + | |
| TGCTTTTACG | 7 | 20 | 6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) | NM_025273 | + | |
| ATTACGGTGG | 7 | 18 | aldo-keto reductase family 1, member A4 (aldehyde reductase) | NM_021473 | + | |
| AAGACCTATG | 12 | 2 | diazepam binding inhibitor | NM_007830 | − | |
| CTCCTGCAGC | 15 | 29 | esterase 10 | NM_016903 | + | |
| ATCTGACTCC | 3 | 10 | hemoglobin Y, beta-like embryonic chain | NM_008221 | + | |
| TAAAGCAAAA | 20 | 43 | H2B histone family, member S | NM_023422 | + | |
| GACTTCACGC | 155 | 182 | kidney androgen-regulated protein | NM_010594 | + | |
| GCACGAGCGT | 7 | 0 | low density lipoprotein receptor-related protein 2 | XM_130363 | − | |
| TGCTGTGACC | 9 | 16 | membrane-associated protein 17 pending | NM_026018 | + | |
| TGTGCTTCCC | 4 | 12 | neural precursor cell expressed, developmentally down-regulated gene 8 | NM_008683 | + | |
| TGAGCGCTGC | 15 | 24 | PDZ domain containing 1 | NM_021517 | + | |
| GGGGAGGGGG | 7 | 0 | pre B-cell leukemia transcription factor 2 | NM_017463 | − | |
| GGCTGGGGGC | 3 | 10 | profilin 1 | NM_011072 | + | |
| AAGTAAAGCG | 6 | 12 | SEC61, gamma subunit (S. cerevisiae) | NM_011343 | + | |
| CAGCCTGAGC | 4 | 10 | selenoprotein R | NM_013759 | + | |
| TTTCCAGGTG | 1 | 8 | selenoprotein W, muscle 1 | NM_009156 | + | |
From Applied Biosystems (http://myscience.appliedbiosystems.com/cdsEntry/Form/gene_expression_keyword.jsp.).
+, up-regulation; −, down-regulation.
Figure 1Confirmation of SAGE data by real-time RT-PCR analysis. The variation of the amplification of the expression in groups 1 and 2 [UN(−)/UN(+)] is plotted. PCR analyses were performed on cDNA from UN(−) or UN(+) tissues.
Figure 2Measurement of hydrogen peroxide already formed in kidney tissue. An increase in H2O2 level was induced by UN in a dose-dependent manner. Data shown represent means ± SE of three independent experiments (n = 4). *p < 0.05 versus control.
Figure 3Cellular pathways triggered in response to UN long-term exposure. Some genes or molecules, which present an altered expression level after uranium ingestion, emphasize the implication of these cellular processes in UN long-term exposure (in parentheses).